You are here: Industry Insights > Pfizer

News List

Relugolix shows potential long-term benefit in women with uterine fibroids pharmatimes
March 26, 2021
Pfizer and Myovant Sciences have announced that relugolix combination therapy could have ‘potential benefit’ for the long-term treatment of women with uterine fibroids.
Pfizer begins trial of oral antiviral therapeutic agent for Covid-19 pharmaceutical-technology
March 25, 2021
Pfizer has initiated a Phase I study of an investigational, novel oral antiviral therapeutic, PF-07321332, for SARS-CoV-2 virus that causes Covid-19, in healthy adult subjects in the US.
Antibodies generated by COVID-19 vaccines less effective against some variants: US Study expresspharma
March 15, 2021
According to the scientists, the two strains first described in Brazil and Japan were five to seven times more resistant, compared to the original SARS-CoV-2 virus lineage from Wuhan, China.
A single vaccine dose is sufficient for immunity in COVID-19 survivors, finds study europeanpharmaceuticalreview
March 12, 2021
New research shows a second COVID-19 vaccine dose may be unnecessary in individuals previously infected with SARS-CoV-2 and needlessly exposes individuals to higher rates of adverse effects.
New real-world evidence for Pfizer/BioNTech COVID-19 vaccine pharmatimes
March 12, 2021
New real-world evidence gathered by the Israel Ministry of Health (MoH) suggests that Pfizer/BioNTech’s COVID-19 vaccine ‘dramatically’ lowers the incidence rates of COVID-19 in fully vaccinated individuals.
Pfizer interested in producing vaccine in India if speedy clearance, export freedom assured: Reports expresspharma
March 11, 2021
Pfizer has told the Indian government it wants to produce its coronavirus vaccine locally if assured of faster regulatory clearance and freedom on pricing and exports, two sources with direct knowledge of the matter told Reuters.
Genome and Company signs second clinical trial collaboration and supply agreement (Phase 2) with Merck KGaA, Darmstadt, Germany and Pfizer for immuno-oncology microbiome study prnasia
March 10, 2021
Genome and Company, a leading global microbiome anti-cancer drug development company, signed a second clinical trial collaboration and supply agreement (CTCSA) with Merck KGaA, Darmstadt, Germany and Pfizer Inc. with the aim of developing the world's ...
US accuses Russia of Covid-19 vaccine disinformation campaign pharmaceutical-technology
March 10, 2021
The US Government has accused the Russian intelligence services of carrying out a disinformation campaign aimed at undermining confidence in Western-produced Covid-19 vaccines, including Pfizer and BioNTech’s mRNA product.
COVID-19 booster shots more likely as variants could cut efficacy of vaccines: GlobalData expresspharma
March 10, 2021
Pfizer and Moderna are already working on developing booster shots for their vaccines to improve their effectiveness against the B.1.351 strain.
Pfizer COVID-19 vaccine works against Brazil variant in lab study expresspharma
March 09, 2021
The scientists said the neutralising ability was roughly equivalent to the vaccine’s effect on a previous less contagious version of the virus from last year.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 83 84 Next page